Epithalon (Epitalon)

Epithalon (also spelled Epitalon) is a synthetic tetrapeptide originally developed by Russian researcher Vladimir Khavinson. Research indicates this four-amino-acid sequence (Ala-Glu-Asp-Gly) may activate telomerase enzyme activity in human cells, potentially promoting telomere maintenance. Studies suggest epithalon may also influence pineal gland function and melatonin production, while appearing to modulate various age-related biomarkers in both animal models and limited human trials.

The existing research on epithalon consists primarily of small-scale studies and animal experiments, with only a few limited human trials involving fewer than 100 total participants. Studies suggest potential effects on telomere length, circadian rhythms, and certain aging biomarkers, though the clinical significance and long-term safety profile remain unclear. Most research has been conducted by a small group of researchers, primarily in Russia, and many studies lack the scale and rigor needed for definitive conclusions.

Currently available through research chemical suppliers in an unregulated market, epithalon's quality, purity, and safety cannot be guaranteed. The peptide requires careful storage and handling, and its legal status as a research chemical means it is not approved for human consumption in most jurisdictions. Given the limited safety data and unregulated nature of available products, epithalon represents a high-risk intervention with theoretical potential but substantial unknowns regarding both efficacy and safety.